• contact us
  • home
  • rho
  • rho canada ventures
  • rho fund investors
  • rho acceleration
  • twitter   follow us
search
rho Logo
    • Rho Ventures Investing Approach
    • Rho Values
    • Fast Facts
    • Overview
    • Partners
    • Principals
    • Chief Financial Officer
    • Key Successes
    • Investments
    • Case Studies
    • Energy Technology
    • Healthcare
    • IT & Communications
    • New Media
Portfolio > Healthcare > Select Historical > GynoPharma

GynoPharma

Sector:
Healthcare

Year Funded:
1986

Status:
Acquired by Ortho-McNeil (now J&J)



Summary:

GynoPharma was the first to market the ParaGard copper IUD in the United States. 

 

Key Successes
Investments
Case Studies
Energy Technology
Healthcare
Current
Select Historical
3DP
Anacor
AqueSys
Archemix
Dendreon
Dyax
Genetic Therapy
Gloucester Pharmaceuticals
GynoPharma
Human Genome Sciences
LeukoSite
MedImmune
Memory Pharmaceuticals
MPV
NephroGenex
NitroMed
Health Allies
Osteotech
Pharmavene
PHT
Principia
SARcode Bioscience, Inc.
Senomyx
STC
Tercica
TolerRx
Upstate
Vanda
Verathon
Vicuron
Virus Research
IT & Communications
New Media
  • Copyright © 2018 Rho Ventures. All rights reserved